European Journal of Epidemiology

, Volume 29, Issue 6, pp 383–390

Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?

COMMENTARY

DOI: 10.1007/s10654-014-9898-z

Cite this article as:
James, J.E. Eur J Epidemiol (2014) 29: 383. doi:10.1007/s10654-014-9898-z

Keywords

Personalised medicine Inverse care law Inverse benefit law Preventive medicine GWAS Omic technologies Pharmacogenomics 

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  1. 1.Reykjavík UniversityReykjavíkIceland
  2. 2.National University of IrelandGalwayIreland

Personalised recommendations